Skip to main content
Download PDF
Download ePub

Childhood obesity and risk of Alzheimer’s disease: a Mendelian randomization study

Archives of Public Health volume 82, Article number: 39 (2024) Cite this article

Abstract

Background

Midlife obesity is a modifiable risk factor for Alzheimer’s disease. However, the association between childhood obesity and Alzheimer’s disease remains largely unknown. Therefore, we conducted a mendelian randomization analysis (MR) to assess the causal link between childhood obesity and Alzheimer’s disease.

Methods

Using summary statistics from publicly available genome-wide association studies (GWAS) database, we explored the genetic link between childhood obesity and Alzheimer’s disease through a two-sample MR. The primary analysis employed the inverse-variance weighted (IVW) method. To complement our findings, we also employed MR-Egger, weighted median, simple model, and weighted model methods for MR estimates. Furthermore, we conducted Cochrane’s Q-statistic test, Egger intercept test, and a leave-one-out sensitivity test to ensure the robustness and reliability of our results.

Results

The IVW analysis yielded non-significant results, indicating no significant genetic association between childhood obesity and Alzheimer’s disease (OR = 0.958, 95% CI = 0.910–1.008, p = 0.095). Consistent with this, the results from MR-Egger, the weighted median, simple model, and weighted model approaches all supported these findings. Furthermore, we did not detect any signs of heterogeneity or pleiotropy, and our leave-one-out analysis confirmed that no single nucleotide polymorphisms had a substantial impact on the reliability of our results.

Conclusions

The evidence from our MR analyses suggests that there is no causal effect of childhood obesity on the risk of Alzheimer’s disease.

Peer Review reports

Text box 1. Contributions to the literature

• Public health policies targeting Alzheimer’s disease risk factors among early life course-related traits are urgently needed.

• Healthcare systems should give due importance to the impact of childhood obesity on adulthood and later life.

• There is limited evidence on contributions of healthcare systems and public health policies in childhood obesity in Alzheimer’s disease.

Background

Alzheimer’s disease is a progressive neurodegenerative disorder that manifests as a gradual decline in cognitive function, ultimately resulting in severe impairment and loss of independence. This condition affects more than 27 million individuals and stands as the predominant form of dementia among the elderly population [1, 2]. Therefore, Alzheimer’s disease has emerged as a significant public health concern and a top priority for research. Despite ongoing efforts, the precise cause of Alzheimer’s disease remains elusive. Notably, the primary risk factors for Alzheimer’s disease include age, genetics, and family history, all of which are non-modifiable [3, 4]. Growing evidence supports twelve modifiable risk factors for dementias modelled by the 2020 Lancet Commission [5]. It has been estimated that approximately one-third of all global cases of Alzheimer’s disease can be attributed to modifiable risk factors [6]. Moreover, a reduction in these modifiable risk factors by 10–25% could potentially prevent up to 3 million cases of Alzheimer’s disease globally [7]. These emphasize the potential impact of addressing these modifiable factors in reducing the overall burden of the disease. One of the identified twelve modifiable risk factors for dementia is midlife (45–65 years) obesity, which has been found to be predictive of future Alzheimer’s disease [5, 8,9,10,11]. Research indicates that Alzheimer’s disease may start developing 20 years or more before symptoms arise [12]. In the 2017 Lancet Commission, a life-course model was proposed to explore potentially modifiable risks for dementia [13]. Considering the significance of the life course in understanding risks, it is important to investigate whether childhood obesity can predict the development of Alzheimer’s disease in the future.

Most of the recent data has primarily examined the link between obesity and Alzheimer’s disease in adults. Numerous potential mechanisms have been proposed to explain the connection between obesity and Alzheimer’s disease, including systemic inflammation, activation of astroglia, plaque deposition, and impaired plaque clearance [14]. With the increased prevalence of obesity and the earlier onset of obesity in the population, there may be a significant rise in the incidence and prevalence of Alzheimer’s disease among younger individuals [15]. Childhood obesity, which is highly prevalent, has been linked to various health issues, including cognitive impairment during childhood [16, 17]. Longitudinal studies examining the association between childhood obesity and cognitive function in midlife have revealed that childhood obesity has a detrimental effect on cognition later in life [18]. These findings suggest that factors influencing cognitive function in midlife may already be present during childhood. Additionally, research supports a connection between lower midlife cognitive function and the development of dementia in older age [19]. Based on these observations, it is plausible to speculate that childhood obesity increases the risk of cognitive impairment in midlife and ultimately contributes to the development of Alzheimer’s disease.

Clarifying the causal link between childhood obesity and Alzheimer’s disease is of utmost importance, as it will enable us to better prepare for the substantial influx of future Alzheimer’s disease patients.

Methods

Study design and data sources

We conducted a two-sample MR study using publicly available data from genome-wide association studies (GWAS). Since we relied on existing data, no additional ethical approvals were required. In MR studies, genetic information is utilized as instrumental variables (IVs) [20]. In our study, childhood obesity was considered as the exposure, Alzheimer’s disease as the outcome, and single nucleotide polymorphisms (SNPs) as the IVs. To obtain SNPs associated with childhood obesity, we utilized data from the Early Growth Genetics (EGG) consortium. This dataset included 5,530 patients (in the 95th percentile of body mass index (BMI) for their age [21]) and 8,318 controls (in the below 50th percentile of BMI) from European children [22]. Exposure to SNPs of childhood BMI was obtained from another publicly available GWAS dataset with a total sample size of 61,111 European children aged between 2 and 10 years [23]. The data for the outcome, Alzheimer’s disease, was sourced from another publicly available GWAS dataset, comprising 21,982 patients and 41,944 controls from European populations [24]. To achieve a more stable result, we conducted the primary MR analyses in other datasets of Alzheimer’s disease. Dataset for Alzheimer’s disease-repeated comprised 39,106 patients and 46,828 controls from European populations [25]. A schematic view of the study design is shown in Fig. 1. The rationale of our MR design was based on three assumptions: (1) genetic variation is robustly associated with childhood obesity; (2) genetic variation is not associated with other confounders; (3) genetic variation only influences the outcome by childhood obesity.

Fig. 1
figure 1

Schematic view of design and three key assumptions of the Mendelian randomization study

Full size image

Genetic instrumental variables selection

To ensure effective instrumental variables (IVs) that fulfill the three key MR assumptions, we performed a set of quality control techniques. Firstly, we identified 6 SNPs as IVs representing childhood obesity to conduct MR analysis in the threshold of p < 5 × 10− 8. As MR studies require at least 10 IVs [26, 27], we extract 15 SNPs using a threshold of p < 5 × 10− 6 [28, 29]. To eliminate weak instrument bias, F statistics were calculated and an F < 10 was considered dubious bias [28]. To validate these SNPs, we conducted phenome-wide association studies (pheWAS) utilizing catalog databases, confirming that there were no potential relationships between these SNPs and any measured or unmeasured confounding factors [30, 31]. Secondly, we applied a minor allele frequency (MAF) threshold of 0.01 to ensure that the selected SNPs were meaningful in terms of their frequency within the population. Thirdly, we utilized a clumping process with an r2 < 0.001 and a clumping distance of 10,000 kb to select SNPs with low linkage disequilibrium (LD) levels. Lastly, we ensured that the effects of the selected SNPs on the exposure (childhood obesity) corresponded to the same allele as the effect on the outcome (Alzheimer’s disease). Any palindromic SNPs were excluded from our IVs to maintain the integrity of our analysis.

Two-sample MR analysis

In our study, the main MR analysis was conducted using the classic inverse-variance weighted (IVW) method to evaluate the causal effect of childhood obesity on Alzheimer’s disease. The IVW method is known for providing a stable and accurate causal evaluation when there is no evidence of directional pleiotropy [20, 32]. In addition to the IVW method, we also employed other MR analysis methods to estimate causal effects. These methods included MR-Egger regression, weighted median, simple model, and weighted model methods. The MR-Egger regression method is particularly useful when there is potential for directional pleiotropy. This method allows for the assessment of causal effects even in the presence of unbalanced horizontal pleiotropy [33]. The weighted median method estimates the causal effect by taking the median of the individual instrumental variable estimates, allowing for robustness against potential violations of the instrumental variable assumptions [34]. Similarly, the simple model [34] and weighted model [35] methods provide alternative approaches to estimate causal effects, offering additional insights in cases where assumptions underlying the IVW method may be violated.

By employing multiple MR analysis methods, we aimed to obtain a comprehensive understanding of the causal relationship between childhood obesity and Alzheimer’s disease, considering the strengths and limitations of each approach.

Sensitivity analyses

To assess the heterogeneity and potential pleiotropy among the IVs, we conducted Cochrane’s Q-statistic test and Egger intercept test. These tests allow us to examine the presence of heterogeneity in causal estimates and detect potential bias caused by horizontal pleiotropy. Additionally, we performed leave-one-out analyses to examine the robustness of the MR results. This analysis involves systematically excluding one IV at a time and re-estimating the causal effect to assess the influence of individual IVs on the overall estimate. In all sensitivity analyses, we utilized a p-value threshold of 0.05 to determine statistical significance.

All MR and sensitivity analyses were conducted in R (version 4.3.1) using the Two-Sample MR package (version 0.5.7).

Results

SNPs used as instrumental variables

We identified independent SNPs from the GWAS dataset following the methodology described in the previous section. The remaining 15 SNPs were included to establish the genetic IVs for childhood obesity (Table 1). F statistics were calculated to estimate weak instrument bias considering the relatively relaxed threshold in childhood obesity, and an F < 10 was considered dubious bias.

Table 1 Childhood obesity SNPs used to construct the instrument variables
Full size table

MR analysis of childhood obesity and Alzheimer’s disease

The MR analysis conducted in this study aimed to investigate the causal relationship between childhood obesity and Alzheimer’s disease risk. First, we analyzed the causal relationship between childhood BMI and Alzheimer’s disease risk. There is no causal relationship between childhood BMI and the risk of Alzheimer’s disease using the IVW analysis (Odds Ratio [OR] 0.989, 95% Confidence Interval [CI] [0.846, 1.152], p = 0.886). This finding was consistent across different MR analysis methods, including MR-Egger (OR 0.791, 95% CI [0.419, 1.494], p = 0.482), simple model (OR 0.905, 95% CI [0.684, 1.196], p = 0.492), weighted model (OR 0.892, 95% CI [0.701, 1.135], p = 0.368), and weighted median (OR 0.916, 95% CI [0.775, 1.084], p = 0.308) analyses (Table S1, Figure S1).

However, we remain open to the possibility of a non-linear causal relationship between childhood BMI and Alzheimer’s disease. Then we conducted childhood obesity as instrumental variables and no significant causal effect of the genetic risk variants on Alzheimer’s disease was observed using the IVW analysis (Odds Ratio [OR] 0.958, 95% Confidence Interval [CI] [0.910, 1.008], p = 0.095). This finding was consistent across different MR analysis methods, including MR-Egger (OR 0.959, 95% CI [0.741, 1.241], p = 0.755), simple model (OR 0.973, 95% CI [0.866, 1.094], p = 0.658), weighted model (OR 0.967, 95% CI [0.865, 1.081], p = 0.563), and weighted median (OR 0.962, 95% CI [0.898, 1.030], p = 0.265) analyses (Figs. 2 and 3). To achieve a more stable result, we repeated the primary MR analyses in other datasets of Alzheimer’s disease and got the same results (Figs. 2 and 3). These results suggest that there is no causal relationship between childhood obesity and the risk of Alzheimer’s disease.

Fig. 2
figure 2

Associations between genetically predicted childhood obesity and Alzheimer’s disease risk. OR, odds ratio; CI, confidence interval

Full size image
Fig. 3
figure 3

Plots of MR estimates of the causal relationship between childhood obesity and Alzheimer’s disease. (A) The scattered plot of SNPs associated with childhood obesity and their risk on Alzheimer’s disease. (B) Forest plot of SNPs associated with childhood obesity and their risk on Alzheimer’s disease. (C) The scattered plot of SNPs associated with childhood obesity and their risk on Alzheimer’s disease in other datasets. (D) Forest plot of SNPs associated with childhood obesity and their risk on Alzheimer’s disease in other datasets. SNPs, single nucleotide polymorphisms

Full size image

Sensitivity analysis

To ensure the reliability of our findings, we conducted a sensitivity analysis. The IVW and MR-Egger tests for heterogeneity revealed no statistically significant heterogeneity in the MR analysis results between childhood obesity and Alzheimer’s disease (p > 0.05), as shown in Table 2. This indicates that our results are not confounded by other factors within the populations grouped by instrumental variables. Additionally, we investigated the presence of horizontal pleiotropy in our MR analysis. The results indicated that there was no significant horizontal pleiotropy effect (p > 0.05), as presented in Table 2. Figure 4 presents the outcomes of this leave-one-out sensitivity analysis. It visually represents the effects of excluding each SNP on the estimated causal relationship between childhood obesity and Alzheimer’s disease. By observing the changes in the results with the removal of each SNP, we can assess the robustness and reliability of the overall findings.

Table 2 Heterogeneity and horizontal pleiotropy tests for causal effects of childhood obesity on Alzheimer’s disease
Full size table
Fig. 4
figure 4

A leave one-out pleiotropy test was performed for each SNP to determine the robustness of the MR test. (A) Childhood obesity - Alzheimer’s disease. (B) Childhood obesity - Alzheimer’s disease repeated. SNP, single-nucleotide polymorphism

Full size image

Discussion

Based on our MR study findings, we do not find support for a causal association between genetically predicted childhood obesity and Alzheimer’s disease risk.

It is worth noting that obesity and Alzheimer’s disease exhibit similarities in terms of shared features such as chronic inflammation, increased oxidative stress, and impaired energy metabolism [36]. However, the results of previous observational studies examining the association between obesity and Alzheimer’s disease have shown inconsistencies, particularly in relation to age. One comprehensive review of 19 longitudinal studies, including a large cohort of 589,649 participants with up to 42 years of follow-up, reported an association between midlife obesity and an increased risk of dementia in late life [37]. Additionally, a prospective population-based cohort study found that midlife obesity was predictive of an earlier onset of Alzheimer’s disease and higher levels of neuropathology. Conversely, maintaining a healthy BMI during midlife appeared to delay the onset of Alzheimer’s disease [38]. However, when focusing on obesity in late life, the relationship with Alzheimer’s disease appears to have different dynamics. A population-based prospective cohort study reported a reversed risk estimation, indicating that higher baseline BMI in late life was associated with a reduced risk of Alzheimer’s disease [39]. Similarly, another prospective study found that obesity in late life was associated with a lower risk of dementia compared to individuals with a normal BMI [40].

Although midlife obesity has been found to be predictive of future Alzheimer’s disease, 70% of obese adults were not obese in childhood or adolescence [41]. Moreover, the majority of adult obesity-related morbidity occurs in adults who were not obese during childhood [42]. Currently, little is known about the potential risk of childhood obesity in relation to Alzheimer’s disease in later life, despite the fact that childhood obesity can lead to significant health consequences that often become apparent during adulthood [43]. One large cohort study demonstrated a negative effect of childhood obesity on midlife cognitive function [18]. We found no causal association of childhood BMI with Alzheimer’s disease, which consistent with two previous MR studies about causal relationship of early life course-related traits with psychiatric disorders [44, 45]. However, we remain open to the possibility of a non-linear causal relationship between childhood BMI and Alzheimer’s disease. The objective of our current research is to investigate the potential associations between genetically determined childhood obesity and Alzheimer’s disease. This perspective is important to consider in the broader context of understanding long-term health implications of childhood obesity and its potential influence on later-life cognitive health. Due to the strong correlation between childhood obesity and the development of diabetes and hypertension in adulthood [42], both of which are considered modifiable risk factors for Alzheimer’s disease [5]. It becomes challenging to ascertain the independent effects of childhood obesity. By using genetically predicted childhood obesity as instrumental variables, we aimed to minimize the potential influence of confounders. Consequently, our study found no causal association between genetically predicted childhood obesity and the risk of Alzheimer’s disease.

Conclusions

In contrast to midlife obesity, which has been identified as a modifiable risk factor for Alzheimer’s disease, our findings suggest that childhood obesity does not have a causal association with the risk of developing Alzheimer’s disease. This discrepancy highlights the possibility that obesity during different stages of life may be differentially associated with the risk of Alzheimer’s disease. Future studies should consider examining the potential mechanisms underlying the differing associations between obesity during different life periods and Alzheimer’s disease risk. Such investigations can contribute to a more comprehensive understanding of the impact of obesity on the development and progression of Alzheimer’s disease.

Limitations

However, there are limitations to this MR study. First, few SNPs fell under the standard bioinformatic threshold of p < 5 × 10− 8. Consequently, we opted to select SNPs using a less stringent significance level of 5 × 10− 6, as employed in previous studies [28, 29]. Therefore, weak instrumental bias may exist, we calculated F statistics to assess the risk of such bias and an F < 10 was considered dubious bias. Second, due to data limitations in the original studies, we were unable to conduct subgroup analyses based on demographic factors such as gender, ethnicity, and education. Third, it is important to highlight that the only publicly available GWAS dataset for childhood obesity did not provide specific information on weight, height, and abdominal circumference. Consequently, we were unable to conduct subgroup analyses based on obesity classifications. This limitation restricted our ability to investigate potential variations in the relationship between different obesity classes and Alzheimer’s disease.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

MR:

Mendelian randomization

GWAS:

Genome-wide association studies

IVW:

Inverse-variance weighted

IVs:

Instrumental variables

SNPs:

Single nucleotide polymorphisms

BMI:

Body mass index

EGG:

Early Growth Genetics

References

  1. Silva M, Loures C, Alves L, de Souza LC, Borges K, Carvalho M. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Rostagno AA. Pathogenesis of Alzheimer’s Disease. Int J Mol Sci. 2022;24(1).

  3. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer’s disease. Lancet. 2011;377(9770):1019–31.

    Article  PubMed  Google Scholar 

  4. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406.

  5. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94.

    Article  PubMed  Google Scholar 

  7. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10(9):819–28.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2010;67(6):505–12.

    Article  PubMed  Google Scholar 

  9. Roh E, Hwang SY, Kim JA, Lee YB, Hong SH, Kim NH, Seo JA, Kim SG, Kim NH, Choi KM, et al. Body weight variability increases dementia risk among older adults: a Nationwide Population-based Cohort Study. Front Endocrinol (Lausanne). 2020;11:291.

    Article  PubMed  Google Scholar 

  10. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1037–45.

    Article  CAS  PubMed  Google Scholar 

  11. Chuang YF, An Y, Bilgel M, Wong DF, Troncoso JC, O’Brien RJ, Breitner JC, Ferruci L, Resnick SM, Thambisetty M. Midlife adiposity predicts earlier onset of Alzheimer’s dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Mol Psychiatry. 2016;21(7):910–5.

    Article  CAS  PubMed  Google Scholar 

  12. Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Graber S, Kuder-Buletta E, LaFougere C, Laske C, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat Med. 2019;25(2):277–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–734.

    Article  PubMed  Google Scholar 

  14. Martin-Jimenez CA, Gaitan-Vaca DM, Echeverria V, Gonzalez J, Barreto GE. Relationship between obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View. Mol Neurobiol. 2017;54(9):7096–115.

    Article  CAS  PubMed  Google Scholar 

  15. Naderali EK, Ratcliffe SH, Dale MC. Obesity and Alzheimer’s disease: a link between body weight and cognitive function in old age. Am J Alzheimers Dis Other Demen. 2009;24(6):445–9.

    Article  PubMed  Google Scholar 

  16. Wang C, Chan JS, Ren L, Yan JH. Obesity Reduces Cognitive and Motor Functions across the Lifespan. Neural Plast. 2016;2016:2473081.

  17. Marti-Nicolovius M. [Effects of overweight and obesity on cognitive functions of children and adolescents]. Rev Neurol. 2022;75(3):59–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Tait JL, Collyer TA, Gall SL, Magnussen CG, Venn AJ, Dwyer T, Fraser BJ, Moran C, Srikanth VK, Callisaya ML. Longitudinal associations of childhood fitness and obesity profiles with midlife cognitive function: an Australian cohort study. J Sci Med Sport. 2022;25(8):667–72.

    Article  PubMed  Google Scholar 

  19. Knopman DS, Gottesman RF, Sharrett AR, Tapia AL, DavisThomas S, Windham BG, Coker L, Schneider A, Alonso A, Coresh J, et al. Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: the atherosclerosis risk in communities Study. Alzheimers Dement. 2018;14(11):1406–15.

    Article  PubMed  Google Scholar 

  20. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.

    Article  MathSciNet  PubMed  Google Scholar 

  21. Flegal KM, Wei R, Ogden C. Weight-for-stature compared with body mass index-for-age growth charts for the United States from the Centers for Disease Control and Prevention. Am J Clin Nutr. 2002;75(4):761–6.

    Article  CAS  PubMed  Google Scholar 

  22. Bradfield JP, Taal HR, Timpson NJ, Scherag A, Lecoeur C, Warrington NM, Hypponen E, Holst C, Valcarcel B, Thiering E, et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet. 2012;44(5):526–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Vogelezang S, Bradfield JP, Ahluwalia TS, Curtin JA, Lakka TA, Grarup N, Scholz M, van der Most PJ, Monnereau C, Stergiakouli E, et al. Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits. Plos Genet. 2020;16(10):e1008718.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54(4):412–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gao X, Meng LX, Ma KL, Liang J, Wang H, Gao Q, Wang T. The bidirectional causal relationships of insomnia with five major psychiatric disorders: a mendelian randomization study. Eur Psychiatry. 2019;60:79–85.

    Article  PubMed  Google Scholar 

  27. Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, Nagel M, Awasthi S, Barr PB, Coleman J, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50(7):912–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zou XL, Wang S, Wang LY, Xiao LX, Yao TX, Zeng Y, Zhang L. Childhood obesity and risk of stroke: a mendelian randomisation analysis. Front Genet. 2021;12:727475.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Cao Z, Wu Y, Li Q, Li Y, Wu J. A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample mendelian randomization analysis. Ann Med. 2022;54(1):1636–45.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Carroll RJ, Bastarache L, Denny JC. R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment. Bioinformatics. 2014;30(16):2375–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Huang JY, Labrecque JA. From GWAS to PheWAS: the search for causality in big data. Lancet Digit Health. 2019;1(3):e101–3.

    Article  PubMed  Google Scholar 

  32. Burgess S, Scott RA, Timpson NJ, Davey SG, Thompson SG. Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543–52.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Bowden J, Davey SG, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bowden J, Davey SG, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hartwig FP, Davey SG, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Litwiniuk A, Bik W, Kalisz M, Baranowska-Bik A. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease. Int J Mol Sci. 2021;22(11).

  37. Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, Egan K. Body mass index in midlife and dementia: systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst). 2017;8:165–78.

    Article  PubMed  Google Scholar 

  38. Chuang YF, An Y, Bilgel M, Wong DF, Troncoso JC, O’Brien RJ, Breitner JC, Ferrucci L, Resnick SM, Thambisetty M. Correction: Midlife adiposity predicts earlier onset of Alzheimer’s dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Mol Psychiatry 2023.

  39. Hughes TF, Borenstein AR, Schofield E, Wu Y, Larson EB. Association between late-life body mass index and dementia: The Kame Project. Neurology 2009;72(20):1741–1746.

  40. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WJ, Luchsinger JA. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66(3):336–42.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Simmonds M, Llewellyn A, Owen CG, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17(2):95–107.

    Article  CAS  PubMed  Google Scholar 

  42. Llewellyn A, Simmonds M, Owen CG, Woolacott N. Childhood obesity as a predictor of morbidity in adulthood: a systematic review and meta-analysis. Obes Rev. 2016;17(1):56–67.

    Article  CAS  PubMed  Google Scholar 

  43. Weihrauch-Bluher S, Schwarz P, Klusmann JH. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism. 2019;92:147–52.

    Article  PubMed  Google Scholar 

  44. Li X, Tian Y, Yang YX, Ma YH, Shen XN, Chen SD, Dong Q, Tan L, Yu JT. Life Course Adiposity and Alzheimer’s Disease: a mendelian randomization study. J Alzheimers Dis. 2021;82(2):503–12.

    Article  CAS  PubMed  Google Scholar 

  45. He R, Mo J, Zhu K, Luo Q, Liu X, Huang H, Sheng J. The early life course-related traits with three psychiatric disorders: a two-sample mendelian randomization study. Front Psychiatry. 2023;14:1098664.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Data analysis on obesity and Alzheimer’s disease are available through the GWAS database. The authors thank these researchers for their selfless sharing.

Funding

This research was funded by National Natural Science Foundation of China (grant number 82301381) and the Natural Science Foundation of Hunan Province of China (grant number 2021JJ40942).

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, 410013, China

    Wenxiang Qing

  2. Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, 410008, China

    Yujie Qian

Authors
  1. Wenxiang Qing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yujie Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WQ extracted and analyzed the data from GWAS database and wrote the first draft of the paper. YQ conceptualized the research aims, planned the analyses and provided comments. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yujie Qian.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qing, W., Qian, Y. Childhood obesity and risk of Alzheimer’s disease: a Mendelian randomization study. Arch Public Health 82, 39 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s13690-024-01271-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s13690-024-01271-y

Keywords

Archives of Public Health

ISSN: 2049-3258